YD Bio Ltd
YDESNasdaq
$2.27
↓ -7.3%Jul 20 close · end-of-day
Price
1Y↓ -81.8%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$163.5M
Enterprise Value
$157.5M
P/E
—
P/S
273.9
P/B
—
EV/EBITDA
—
PEG
—
FCF Yield
-4.9%
Dividend Yield
—
Revenue (TTM)
$596,817.00
Net Income (TTM)
-$8.3M
Free Cash Flow (TTM)
-$8.0M
Gross Margin
28.1%
Operating Margin
-883.3%
Net Margin
-1392.6%
ROE
291.1%
ROIC
—
Debt / Equity
-0.0
Net Cash
$6.0M
Return 1Y
—
Company profile
- Headquarters
- TX
Earnings
No reported earnings periods on file.
Financial statements
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $350,131.00 | $510,360.00 | $596,817.00 |
| Gross profit | $153,445.00 | $155,356.00 | $167,410.00 |
| Operating income | -$9,847.00 | -$1.5M | -$5.3M |
| Net income | $13,560.00 | -$1.4M | -$8.3M |
| Diluted EPS | $0.00 | -$0.02 | -$0.12 |
| Operating cash flow | -$55,657.00 | -$1.2M | -$6.6M |
| Free cash flow | -$55,947.00 | -$1.3M | -$8.0M |
| Gross margin | 43.8% | 30.4% | 28.1% |
| Operating margin | -2.8% | -286.5% | -883.3% |
| Net margin | 3.9% | -276.6% | -1392.6% |
No quarterly data.
Company news
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | Lu Shao-Ta | Option exercise | 5,749 | — | — | filing |
| 2026-06-30 | Chang Kochi | Option exercise | 5,749 | — | — | filing |
| 2026-03-31 | Lu Shao-Ta | Option exercise | 2,081 | — | — | filing |
| 2026-03-31 | Chang Kochi | Option exercise | 2,081 | — | — | filing |
Latest 4 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.